IM Cannabis (IMCC) Profit After Tax (2020 - 2026)
IM Cannabis (IMCC) posted quarterly Profit After Tax of -$1.8 million for Q1 2026, down 1575.03% year-over-year from $121960.4 in Q1 2025, and up 68.11% quarter-over-quarter from -$5.6 million in Q4 2025.
IM Cannabis (IMCC) Profit After Tax (2020 - 2026) Analysis & Trends
IM Cannabis' Profit After Tax history runs 7 years deep, the most recent figure standing at -$1.8 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 1575.03% year-over-year to -$1.8 million; the TTM figure through Mar 2026 stood at -$4.8 million (up 75.13% YoY), while the FY2025 annual figure was -$8.4 million, up 2.0% from the prior year.
- Profit After Tax for Q1 2026 stood at -$1.8 million, up from -$5.6 million in the prior quarter.
- The five-year high for Profit After Tax was $9.2 million in Q1 2022, with the low at -$98.3 million in Q3 2022.
- The 5-year median for Profit After Tax is -$2.5 million (2024), against an average of -$9.7 million.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax sank 2087.26% in 2022, then surged 454.08% in 2025.
- IM Cannabis' Profit After Tax stood at -$24.6 million in 2022, then soared by 89.51% to -$2.6 million in 2023, then slumped by 518.21% to -$16.0 million in 2024, then jumped by 64.71% to -$5.6 million in 2025, then surged by 68.11% to -$1.8 million in 2026.
- Business Quant data shows IMCC's Profit After Tax at -$1.8 million in Q1 2026, -$5.6 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | -3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.17 Mn |
| Mar 31, 2026 | -1.80 Mn |
| Dec 31, 2025 | -5.64 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Jun 30, 2025 | -140,012.22 |
| Mar 31, 2025 | 121,960.38 |
| Dec 31, 2024 | -15.98 Mn |
| Sep 30, 2024 | -793,163.79 |
| Jun 30, 2024 | -2.53 Mn |
| Mar 31, 2024 | -4.47 Mn |
| Dec 31, 2023 | -2.59 Mn |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -2.76 Mn |
| Mar 31, 2023 | -640,577.05 |
| Dec 31, 2022 | -24.64 Mn |
| Sep 30, 2022 | -98.28 Mn |
| Jun 30, 2022 | -14.89 Mn |
| Mar 31, 2022 | 9.22 Mn |
| Dec 31, 2021 | -9.91 Mn |
| Sep 30, 2021 | -4.49 Mn |